Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
Jacopo Boni, Carlota Rubio-Pérez, Núria López-Bigas, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2106-2106
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Regulation of SIRT1 and Its Roles in Inflammation
Yunshu Yang, Yang Liu, Yunwei Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 369
Pharmacological effects of harmine and its derivatives: a review
Liang Zhang, Deng-chang Li, Shenglan Yu
Archives of Pharmacal Research (2020) Vol. 43, Iss. 12, pp. 1259-1275
Closed Access | Times Cited: 81
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F. Lindberg, Laurent Meijer
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6047-6047
Open Access | Times Cited: 81
Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Emma Lindell, Lei Zhong, Xiaonan Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3762-3762
Open Access | Times Cited: 29
Crosstalk of Hedgehog and mTORC1 Pathways
Lasse Jonsgaard Larsen, Lisbeth Birk Møller
Cells (2020) Vol. 9, Iss. 10, pp. 2316-2316
Open Access | Times Cited: 49
Emerging roles of DYRK2 in cancer
Vasudha Tandon, Laureano de la Vega, Sourav Banerjee
Journal of Biological Chemistry (2020) Vol. 296, pp. 100233-100233
Open Access | Times Cited: 48
Urea-based anticancer agents. Exploring 100-years of research with an eye to the future
Roberta Listro, Giacomo Rossino, Federica Piaggi, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 26
Current senolytics: Mode of action, efficacy and limitations, and their future
Amirhossein Nayeri Rad, Johannes Grillari
Mechanisms of Ageing and Development (2023) Vol. 217, pp. 111888-111888
Open Access | Times Cited: 16
Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies
Michael Tarpley, Helen Oladapo, Dillon Strepay, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 162, pp. 105821-105821
Open Access | Times Cited: 29
DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer
Anna Brichkina, Miriam Ems, Роман В. Суезов, et al.
Gut (2024) Vol. 73, Iss. 10, pp. 1684-1701
Open Access | Times Cited: 4
Inhibition of DYRK1a Enhances Cardiomyocyte Cycling After Myocardial Infarction
A. P. Young, Leigh Bradley, Elizabeth Farrar, et al.
Circulation Research (2022) Vol. 130, Iss. 9, pp. 1345-1361
Open Access | Times Cited: 19
Myocardial DYRK1B Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing
Fatma Bayram, Philipp Hegner, Anna-Maria Lauerer, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 163-163
Open Access
From Dyrk1A inhibitors to a novel class of antiviral agents: Targeting Enterovirus EV-A71 with 2-aryl-substituted thiophene scaffolds
Parthiena M Keddis, Tuong-Khanh My Tu, Hugo Scherer, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117348-117348
Closed Access
Anti-tumor potential of Harmine and its derivatives: recent trends and advancements
Hemant Joshi, Sakshi Bhushan, Tanisha Dimri, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Unravelling Convergent Signaling Mechanisms Underlying the Aging-Disease Nexus Using Computational Language Analysis
Mireia Junyent, Haki Noori, Robin De Schepper, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 189-189
Open Access
The stress-responsive kinase DYRK2 activates heat shock factor 1 promoting resistance to proteotoxic stress
Rita Moreno, Sourav Banerjee, Angus W. Jackson, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 5, pp. 1563-1578
Open Access | Times Cited: 27
A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival
Maribel Lara‐Chica, Alejandro Correa-Sáez, Rafael Jiménez‐Izquierdo, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 1, pp. 105-117
Open Access | Times Cited: 21
DYRK1B inhibition exerts senolytic effects on endothelial cells and rescues endothelial dysfunctions
Francesca Michela Pramotton, Asra Abukar, Chantelle Hudson, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111836-111836
Open Access | Times Cited: 9
G1 Dynamics at the Crossroads of Pluripotency and Cancer
Dalia Fleifel, Jeanette Gowen Cook
Cancers (2023) Vol. 15, Iss. 18, pp. 4559-4559
Open Access | Times Cited: 9
Systems biology approach to identify biomarkers and therapeutic targets for colorectal cancer
Niloufar Sadat Kalaki, Mozhgan Ahmadzadeh, Mohammad Najafi, et al.
Biochemistry and Biophysics Reports (2024) Vol. 37, pp. 101633-101633
Open Access | Times Cited: 3
DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma
Charlotte Martin, Anthony Nguyen, Mo Kang, et al.
Experimental Cell Research (2021) Vol. 405, Iss. 1, pp. 112656-112656
Open Access | Times Cited: 19
A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing
Jia-Wei Tang, Youquan Xie, Jingxun Huang, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 70, pp. 116921-116921
Closed Access | Times Cited: 13
Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
Kyeong‐Min Kim, Sungmin Lee, Hyunkoo Kang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2982-2982
Open Access | Times Cited: 18
Methionine oxidation of CLK4 promotes the metabolic switch and redox homeostasis in esophageal carcinoma via inhibiting MITF selective autophagy
Yaxing Shen, Heng Zhang, Shihua Yao, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents
Noha Mostafa, Po‐Jen Chen, Sarah S. Darwish, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2033-2033
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top